W. Lu

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase 3 trial.

G. Lou, Q. Zhou, B. Kong, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).

M. Zhang, Jun Liu, Xuefeng Yu, 2021, Science bulletin.

Effects of Perioperative Rosuvastatin for Postoperative Delirium After Elderly General Anesthesia Patients: A Randomized, Double-Blind, and Placebo-Controlled Trial

Haiqin Tang, Jing Luo, W. Lu, 2021 .

Effect of Dexmedetomidine on Intestinal Barrier in Patients Undergoing Gastrointestinal Surgery-A Single-Center Randomized Clinical Trial.

Qun Chen, Ying-Ya Cao, Qiancheng Xu, 2021, The Journal of surgical research.

A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

J. Yang, X. Deng, W. Zheng, 2021, medRxiv.

AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL

K. Papp, L. Kristensen, M. Keiserman, 2021 .

RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis

Guoan Chen, Wenqian Tao, D. Ji, 2021, Translational cancer research.

Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort

S. Yang, W. Li, J. Luo, 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma

Zhenzhen Zhang, Yongfeng Chen, W. Lu, 2022, BMC Genomics.

Pembrolizumab vs chemotherapy in patients with advanced/metastatic adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus as second-line therapy: Analysis of the Chinese subgroup in KEYNOTE-181

L. Shen, Y. Cheng, S. Qin, 2019, Annals of Oncology.

Validation of the Clinical Assessment Scale in Autoimmune Encephalitis in Chinese Patients

Yingchi Zhang, Ewen Tu, Jia Liu, 2021, Frontiers in Immunology.